FOUNTAIN VALLEY, Calif., Sept. 5, 2019 /PRNewswire/ -- Nobles Medical Technologies II has received approval from the U.S. Food and Drug Administration (USFDA) to conduct a prospective pivotal clinical trial called "STITCH" for the expanded indication of PFO Closure for Reduction of Recurrent Ischemic Stroke.

WATERTOWN, Mass., Sept. 5, 2019 /PRNewswire/ -- Liaison International, the leader in admissions management and enrollment marketing solutions for higher education, today provided details about the robust third-cycle growth of BioMedCAS™, the Centralized Application Service (CAS™) for biomedical science programs.

SEATTLE, Sept. 5, 2019 /PRNewswire/ -- More than 90% of people who died by suicide showed symptoms of mental health conditions, yet 59% of US adults with a mental health condition received no mental health services in the past year, according to a new

CMAB Biopharma today reports a positive opinion from a recent QP audit conducted by Parexel International Co. CMAB's fully integrated CDMO facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 Good Manufacturing Practice (GMP) guidelines This achievement signals CMAB Biopharma's continuing evolution into an international CDMO capable

WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- The nation's top business leaders recently endorsed a more modern view of

WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- Childhood cancer is more prevalent than previously believed, with global estimates of more than 400,000 new cases diagnosed every year, according to new research from St. Jude Children's Hospital and the University of Washington. In an effort to illustrate and explore the scope of the crisis, U.S.

SEATTLE and VANCOUVER, British Columbia, Sept. 5, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the Company will host its first investor day on

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019. The 10 largest shareholders in InDex Pharmaceuticals Holding AB (publ) were per August 30, 2019 of:

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Sigrid Therapeutics AB, an innovative technology company developing a new class of products to improve human health, including type 2 diabetes, today announces an equity financing round of USD 1.6M. The two times oversubscribed financing round was led by Joyance Partners, a US-based venture ca

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his position in Octobe